5 articles
Five patients now carry the coin-sized wireless implant that sits on the brain's protective membrane rather than penetrating tissue, with one ALS patient decoding nearly 100 Chinese words.
The agency's new policy ending the two-trial requirement was written for drugs, but brain implant makers watching Synchron, Neuralink, and Paradromics navigate FDA are asking whether the same logic could eventually ease their path.
Multiple companies, including Elon Musk's Neuralink, are racing to bring brain-computer interface technology out of research labs and into commercial markets.
Kim Han-sol, a blind YouTuber with 1.68 million subscribers, has publicly applied for Neuralink's Blindsight clinical trial, bringing significant public attention to the experimental vision-restoring brain implant.
Chinese BCI company NeuroXess has surpassed human trial milestones, positioning itself as a direct competitor to Neuralink in the global neural interface market.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.